It can reduce the levels of serum Low-Density Lipoprotein Cholesterol (LDL-C) and apolipoprotein- B (Apo-B), improve the high-density lipoprotein (HDL) functions damaged by dyslipidemia (Song et al., 2013), reduce the formation of neointima after vein transplantation in rats (Sun et al., 2012), and decrease hypertension, angiogenesis imbalance and oxidative stress caused by placental ischemia (Ushida et al., 2016). This evidence concerns the gene APOB and metabolic syndrome.